{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:38:17Z","timestamp":1780735097480,"version":"3.54.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cellimm.2021.104317","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T10:09:00Z","timestamp":1614593340000},"page":"104317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Human splenic myeloid derived suppressor cells: Phenotypic and clustering analysis"],"prefix":"10.1016","volume":"363","author":[{"given":"Kathryn E.","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan P.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse L.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Padussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano M.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Talmadge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2021.104317_b0005","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4049\/jimmunol.1202088","article-title":"Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8\/A9 proinflammatory proteins","volume":"190","author":"Wang","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00262-008-0523-4","article-title":"Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy","volume":"58","author":"Diaz-Montero","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2021.104317_b0015","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00262-011-1028-0","article-title":"Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13","volume":"60","author":"Gabitass","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2021.104317_b0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1097-0215(19970220)74:1<69::AID-IJC12>3.0.CO;2-D","article-title":"Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells","volume":"74","author":"Young","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cellimm.2021.104317_b0025","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4049\/jimmunol.123.2.942","article-title":"Induction of allograft tolerance after total lymphoid irradiation (TLI): development of suppressor cells of the mixed leukocyte reaction (MLR)","volume":"123","author":"Slavin","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0030","first-page":"95","article-title":"Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor","volume":"1","author":"Pak","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104317_b0035","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1158\/0008-5472.CAN-09-3767","article-title":"Immature immunosuppressive CD14+HLA-DR-\/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign","volume":"70","author":"Poschke","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104317_b0040","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.166.1.678","article-title":"Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer","volume":"166","author":"Almand","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0045","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","article-title":"Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes","volume":"69","author":"Rodriguez","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104317_b0050","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00262-012-1294-5","article-title":"Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology","volume":"61","author":"Dumitru","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2021.104317_b0055","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaf8943","article-title":"Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients","volume":"1","author":"Condamine","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0060","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3892\/mmr.2015.4601","article-title":"Expression of arginase I and inducible nitric oxide synthase in the peripheral blood and lymph nodes of HIVpositive patients","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellimm.2021.104317_b0065","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4049\/jimmunol.172.2.989","article-title":"Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species","volume":"172","author":"Kusmartsev","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellimm.2005.01.004","article-title":"l-Arginine modulates CD3\u03b6 expression and T cell function in activated human T lymphocytes","volume":"232","author":"Zea","year":"2004","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0075","doi-asserted-by":"crossref","first-page":"21123","DOI":"10.1074\/jbc.M110675200","article-title":"Regulation of T cell receptor CD3zeta chain expression by L-arginine","volume":"277","author":"Rodriguez","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2021.104317_b0080","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/BF02934081","article-title":"Role of L-arginine, a substrate for nitric oxide-synthase, in gastroprotection and ulcer healing","volume":"32","author":"Brzozowski","year":"1997","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.cellimm.2021.104317_b0085","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells","volume":"182","author":"Corzo","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0090","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1247135","article-title":"The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells","volume":"5","author":"Lu","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cellimm.2021.104317_b0095","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.4049\/jimmunol.1401572","article-title":"The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity","volume":"193","author":"Ostrand-Rosenberg","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0100","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellimm.2021.104317_b0105","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay1863","article-title":"Targeted deletion of PD-1 in myeloid cells induces antitumor immunity","volume":"5","author":"Strauss","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0110","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1158\/1078-0432.CCR-12-1108","article-title":"Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma","volume":"18","author":"Gros","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104317_b0115","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nbt.1991","article-title":"Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE","volume":"29","author":"Qiu","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellimm.2021.104317_b0120","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1093\/bioinformatics\/btz212","article-title":"CytoBackBone: an algorithm for merging of phenotypic information from different cytometric profiles","volume":"35","author":"Leite Pereira","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cellimm.2021.104317_b0125","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0145-2126(92)90120-V","article-title":"FcRIII (CD16) expression on neutrophils from chronic myeloid leukemia. A flow cytometric study","volume":"16","author":"Carulli","year":"1992","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cellimm.2021.104317_b0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s13277-011-0254-6","article-title":"CD15+\/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function","volume":"33","author":"Choi","year":"2012","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cellimm.2021.104317_b0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0090-1229(90)90160-R","article-title":"Isolation, phenotyping, and functional analysis of lymphocytes from human liver","volume":"56","author":"Hata","year":"1990","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.cellimm.2021.104317_b0140","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.4049\/jimmunol.156.12.4707","article-title":"NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1\/VLA-4 interaction","volume":"156","author":"Fogler","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0145","first-page":"279","article-title":"Increase in liver-associated natural killer activity by polyribonucleotides","volume":"6","author":"Twilley","year":"1987","journal-title":"Nat. Immun. Cell Growth Regul."},{"key":"10.1016\/j.cellimm.2021.104317_b0150","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nprot.2016.066","article-title":"Visualization and cellular hierarchy inference of single-cell data using SPADE","volume":"11","author":"Anchang","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cellimm.2021.104317_b0155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc.: Ser. B (Methodol.)"},{"key":"10.1016\/j.cellimm.2021.104317_b0160","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/sj.bmt.1702013","article-title":"Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods","volume":"24","author":"Venditti","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.cellimm.2021.104317_b0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054824","article-title":"Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study","volume":"8","author":"Basso","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cellimm.2021.104317_b0175","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00262-016-1953-z","article-title":"Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients","volume":"66","author":"Jordan","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2021.104317_b0180","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1309\/AJCPPIBH3I1VRWXQ","article-title":"Splenic lymphoid subsets with less well-recognized phenotypes mimic aberrant antigen expression","volume":"140","author":"Aggarwal","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cellimm.2021.104317_b0185","unstructured":"E. Tavukcuoglu, U. Horzum, H. Yanik, A. Uner, D. Yoyen-Ermis, S.K. Nural, B. Aydin, C. Sokmensuer, D. Karakoc, K.B. Yilmaz, E. Hamaloglu, G. Esendagli, Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer, Eur. J. Immunol. n\/a."},{"key":"10.1016\/j.cellimm.2021.104317_b0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jim.2012.04.004","article-title":"Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples","volume":"381","author":"Kotsakis","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cellimm.2021.104317_b0195","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/1753425912463618","article-title":"Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer","volume":"19","author":"Trellakis","year":"2013","journal-title":"Innate Immun."},{"key":"10.1016\/j.cellimm.2021.104317_b0200","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00262-011-1178-0","article-title":"Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth","volume":"61","author":"Porembka","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2021.104317_b0205","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.1701019","article-title":"Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment","volume":"200","author":"Ostrand-Rosenberg","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0210","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2021.104317_b0215","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood.V61.3.600.600","article-title":"Granulocytosis associated with tumor cell production of colony-stimulating activity","volume":"61","author":"Hocking","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2021.104317_b0220","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.19059","article-title":"Paraneoplastic neutrophilic leukaemoid reaction in a patient with melanoma: association between tumour volume and leucocytosis","author":"Fredeau","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cellimm.2021.104317_b0225","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/1097-0142(19870701)60:1<100::AID-CNCR2820600118>3.0.CO;2-9","article-title":"Splenomegaly and solitary spleen metastasis in solid tumors","volume":"60","author":"Klein","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.cellimm.2021.104317_b0230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.exphem.2014.10.013","article-title":"C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients","volume":"43","author":"Wang","year":"2015","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.cellimm.2021.104317_b0235","first-page":"4756","article-title":"Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients","volume":"61","author":"Schmielau","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104317_b0240","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s004320050178","article-title":"The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer","volume":"124","author":"Hirashima","year":"1998","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cellimm.2021.104317_b0245","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/337471a0","article-title":"Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate","volume":"337","author":"Bussolino","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2021.104317_b0250","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/879897","article-title":"Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients","volume":"2014","author":"Khaled","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cellimm.2021.104317_b0255","first-page":"657","article-title":"Flow cytometric analysis of human bone marrow. III. Neutrophil maturation","volume":"4","author":"Terstappen","year":"1990","journal-title":"Leukemia"},{"key":"10.1016\/j.cellimm.2021.104317_b0260","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1073\/pnas.89.7.2804","article-title":"Isolation of a candidate human hematopoietic stem-cell population","volume":"89","author":"Baum","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cellimm.2021.104317_b0265","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1515\/CCLM.2007.025","article-title":"Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients","volume":"45","author":"Groblewska","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cellimm.2021.104317_b0270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00262-015-1782-5","article-title":"Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study","volume":"65","author":"Mandruzzato","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2021.104317_b0275","first-page":"806","article-title":"Stimulation of immune-suppressive bone marrow cells by colony-stimulating factors","volume":"18","author":"Young","year":"1990","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.cellimm.2021.104317_b0280","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","article-title":"Tumor necrosis factor-\u03b1 blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation","volume":"38","author":"Sade-Feldman","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2021.104317_b0285","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","article-title":"Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function","volume":"32","author":"Condamine","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2021.104317_b0290","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.002980","article-title":"Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosis","volume":"10","author":"Chornoguz","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.cellimm.2021.104317_b0295","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1096-1096","article-title":"Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells","volume":"2","author":"Gabrilovich","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2021.104317_b0300","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1084\/jem.20080132","article-title":"Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein","volume":"205","author":"Cheng","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2021.104317_b0305","doi-asserted-by":"crossref","first-page":"39296","DOI":"10.1038\/srep39296","article-title":"PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment","volume":"6","author":"Iwata","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2021.104317_b0310","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12967-020-02389-7","article-title":"Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes\/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1","volume":"18","author":"Okla","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellimm.2021.104317_b0315","first-page":"320","article-title":"PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection, Cancer","volume":"2","author":"MacFarlane","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cellimm.2021.104317_b0320","doi-asserted-by":"crossref","first-page":"xi55","DOI":"10.1093\/annonc\/mdz452.025","article-title":"ER stress of cancer cell SCC25 induces LOX-1-expressed immunosuppressive neutrophils","volume":"30","author":"Wu","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cellimm.2021.104317_b0325","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/imm.12876","article-title":"Endoplasmic reticulum stress induced LOX-1(+) CD15(+) polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma","volume":"154","author":"Nan","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.cellimm.2021.104317_b0330","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.2147\/CMAR.S210545","article-title":"LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression","volume":"11","author":"Chai","year":"2019","journal-title":"Cancer Manag Res."},{"key":"10.1016\/j.cellimm.2021.104317_b0335","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1158\/0008-5472.CAN-04-4505","article-title":"Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion","volume":"65","author":"Zea","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104317_b0340","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41419-018-0803-7","article-title":"CD45+CD33lowCD11bdim myeloid-derived suppressor cells suppress CD8+ T cell activity via the IL-6\/IL-8-arginase I axis in human gastric cancer","volume":"9","author":"Mao","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellimm.2021.104317_b0345","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00262-015-1765-6","article-title":"Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK\/T cell lymphoma: a novel prognostic indicator","volume":"64","author":"Zhang","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2021.104317_b0350","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1189\/jlb.5MA1116-457R","article-title":"Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow","volume":"102","author":"Roussel","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2021.104317_b0355","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.intimp.2012.05.002","article-title":"Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking","volume":"13","author":"Younos","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2021.104317_b0360","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1515\/CCLM.2007.025","article-title":"Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients","volume":"45","author":"Groblewska","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cellimm.2021.104317_b0365","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2478\/ams-2013-0023","article-title":"Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients","volume":"58","author":"\u0141awicki","year":"2013","journal-title":"Adv. Med. Sci."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874921000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874921000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:05:30Z","timestamp":1757804730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874921000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":73,"alternative-id":["S0008874921000368"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2021.104317","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human splenic myeloid derived suppressor cells: Phenotypic and clustering analysis","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2021.104317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104317"}}